92 related articles for article (PubMed ID: 21436212)
1. Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Zafeiriadou E; Patsiaoura K; Katsiki E; Deretzi G; Zavos C; Tsarouchas G; Rakitzi P; Slavakis A
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):498-503. PubMed ID: 21436212
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
Polyzos SA; Kountouras J; Mantzoros CS; Polymerou V; Katsinelos P
Diabetes Obes Metab; 2017 Dec; 19(12):1805-1809. PubMed ID: 28452101
[TBL] [Abstract][Full Text] [Related]
3. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
Hu ZW; Guo JW; Deng XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Devito R; Ciampalini P; Piemonte F; Marcellini M
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1553-61. PubMed ID: 17206944
[TBL] [Abstract][Full Text] [Related]
6. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
Yakaryilmaz F; Guliter S; Savas B; Erdem O; Ersoy R; Erden E; Akyol G; Bozkaya H; Ozenirler S
Intern Med J; 2007 Apr; 37(4):229-35. PubMed ID: 17388862
[TBL] [Abstract][Full Text] [Related]
7. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
8. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
Loguercio C; Andreone P; Brisc C; Brisc MC; Bugianesi E; Chiaramonte M; Cursaro C; Danila M; de Sio I; Floreani A; Freni MA; Grieco A; Groppo M; Lazzari R; Lobello S; Lorefice E; Margotti M; Miele L; Milani S; Okolicsanyi L; Palasciano G; Portincasa P; Saltarelli P; Smedile A; Somalvico F; Spadaro A; Sporea I; Sorrentino P; Vecchione R; Tuccillo C; Del Vecchio Blanco C; Federico A
Free Radic Biol Med; 2012 May; 52(9):1658-65. PubMed ID: 22343419
[TBL] [Abstract][Full Text] [Related]
9. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
[TBL] [Abstract][Full Text] [Related]
10. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
11. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
12. Plasma apelin levels in subjects with nonalcoholic fatty liver disease.
Ercin CN; Dogru T; Tapan S; Kara M; Haymana C; Karadurmus N; Karslioglu Y; Acikel C
Metabolism; 2010 Jul; 59(7):977-81. PubMed ID: 20045153
[TBL] [Abstract][Full Text] [Related]
13. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
[TBL] [Abstract][Full Text] [Related]
14. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
Shieh K; Gilchrist JM; Promrat K
Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
[TBL] [Abstract][Full Text] [Related]
15. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
16. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
Zhou WD; Yang YL; Che ZH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
[TBL] [Abstract][Full Text] [Related]
17. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.
de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R; Gonzalez JM
Diabetes Res Clin Pract; 2008 Jan; 79(1):74-8. PubMed ID: 17766001
[TBL] [Abstract][Full Text] [Related]
18. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
[TBL] [Abstract][Full Text] [Related]
19. Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.
Sofer E; Boaz M; Matas Z; Mashavi M; Shargorodsky M
Metabolism; 2011 Sep; 60(9):1278-84. PubMed ID: 21411114
[TBL] [Abstract][Full Text] [Related]
20. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
